Bsim2 - Company Review
Bsim2 - Company ReviewSummary
BSIM2 is a computer-driven drug discovery company which focuses on new drug candidates for the treatment of neurodegenerative amyloid diseases. The company’s pipeline of molecules for the treatment of diseases includes familial amyloidotic polyneuropathy (FAP), familial amyloidotic cardiomyopathy (FAC) and Alzheimer's disease (AD). Its computer-driven drug discovery is based on computational methodologies and workflows. BSIM2 applies structural bioinformatics and chemoinformatics in discovering and optimizing new drug candidates. The company has partnership with pharmaceutical companies and institutions. It caters pharmaceutical and biotechnology industries. BSIM2 is headquartered in Cantanhede, Portugal.
This comprehensive company report of Bsim2 provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.